Abu Dhabi Bio City

Abu Dhabi Bio City is a premier life sciences and healthcare ecosystem located in Abu Dhabi, United Arab Emirates, operating as a core component of M42 (a joint venture between G42 and Mubadala Health). It serves as a global hub for genomics research, health technology innovation, and biopharmaceutical manufacturing, housing the world-class Omics Centre of Excellence. The facility is the primary engine behind the Emirati Genome Program, one of the most ambitious population-scale genomic initiatives globally, aimed at advancing personalized medicine and predictive healthcare. Abu Dhabi Bio City provides end-to-end infrastructure for clinical trials, advanced diagnostics, and large-scale vaccine production through strategic partnerships with global leaders like Sinopharm and AstraZeneca. By integrating artificial intelligence with biological sciences, the hub aims to transform the UAE into a leading destination for life sciences R&D and to address critical regional and global health challenges.